BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.42−0.07 (-4.70%)
Close on Nov 16, 2026Market cap $36.18MP/E –Yield –
BioRestorative Therapies cash
Cash and short-term investments held at the end of each period.
BioRestorative Therapies's cash was $3.59M at Mar 31, 2026. For fiscal 2025 it was $2.95M, down 72.5% from the year before. Over ten years it grew 33.3% a year on average. The highest annual figure on record is $21.03M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.95M | -72.5% |
| FY2024 | Dec 31, 2024 | $10.73M | -3.0% |
| FY2023 | Dec 31, 2023 | $11.07M | -25.0% |
| FY2022 | Dec 31, 2022 | $14.75M | -29.9% |
| FY2021 | Dec 31, 2021 | $21.03M | +586.1% |
| FY2020 | Dec 31, 2020 | $3.06M | +184071.3% |
| FY2019 | Dec 31, 2019 | $1.66K | -98.6% |
| FY2018 | Dec 31, 2018 | $117.52K | -74.0% |
| FY2017 | Dec 31, 2017 | $451.68K | +1319.4% |
| FY2016 | Dec 31, 2016 | $31.82K | -80.9% |
| FY2015 | Dec 31, 2015 | $166.56K | +81.4% |
| FY2014 | Dec 31, 2014 | $91.80K | -54.4% |
| FY2013 | Dec 31, 2013 | $201.10K | +55298.9% |
| FY2012 | Dec 31, 2012 | $363 | -99.5% |
| FY2011 | Dec 31, 2011 | $71.51K | +295.6% |
| FY2010 | Dec 31, 2010 | $18.07K | +42933.3% |
| FY2009 | Dec 31, 2009 | $42 | – |
| FY2008 | Dec 29, 2008 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $3.59M | -60.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.95M | -72.5% |
| Q3 FY2025 | Sep 30, 2025 | $4.49M | -65.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.38M | -49.7% |
| Q1 FY2025 | Mar 31, 2025 | $9.11M | -44.5% |
| Q4 FY2024 | Dec 31, 2024 | $10.73M | -3.0% |
| Q3 FY2024 | Sep 30, 2024 | $13.09M | +6.9% |
| Q2 FY2024 | Jun 30, 2024 | $14.68M | +26.4% |
| Q1 FY2024 | Mar 31, 2024 | $16.42M | +32.7% |
| Q4 FY2023 | Dec 31, 2023 | $11.07M | -25.0% |
| Q3 FY2023 | Sep 30, 2023 | $12.24M | -25.8% |
| Q2 FY2023 | Jun 30, 2023 | $11.62M | -35.2% |
| Q1 FY2023 | Mar 31, 2023 | $12.37M | -36.0% |
| Q4 FY2022 | Dec 31, 2022 | $14.75M | -29.9% |
| Q3 FY2022 | Sep 30, 2022 | $16.49M | +1359.4% |
| Q2 FY2022 | Jun 30, 2022 | $17.93M | +919.5% |
| Q1 FY2022 | Mar 31, 2022 | $19.32M | +672.6% |
| Q4 FY2021 | Dec 31, 2021 | $21.03M | +586.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.13M | +541.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.76M | +490.1% |
| Q1 FY2021 | Mar 31, 2021 | $2.50M | +52220.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.06M | +184071.3% |
| Q3 FY2020 | Sep 30, 2020 | $175.99K | +79.4% |
| Q2 FY2020 | Jun 30, 2020 | $298.10K | -76.8% |
| Q1 FY2020 | Mar 31, 2020 | $4.78K | -99.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.66K | -98.6% |
| Q3 FY2019 | Sep 30, 2019 | $98.11K | -6.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.28M | +36274.8% |
| Q1 FY2019 | Mar 31, 2019 | $496.28K | +5694.9% |
| Q4 FY2018 | Dec 31, 2018 | $117.52K | -74.0% |
| Q3 FY2018 | Sep 30, 2018 | $105.37K | +14256.1% |
| Q2 FY2018 | Jun 30, 2018 | $3.53K | +86.6% |
| Q1 FY2018 | Mar 31, 2018 | $8.56K | -3.3% |
| Q4 FY2017 | Dec 31, 2017 | $451.68K | +1319.4% |
| Q3 FY2017 | Sep 30, 2017 | $734 | -88.4% |
| Q2 FY2017 | Jun 30, 2017 | $1.89K | -99.6% |
| Q1 FY2017 | Mar 31, 2017 | $8.86K | – |
| Q4 FY2016 | Dec 31, 2016 | $31.82K | – |
| Q3 FY2016 | Sep 30, 2016 | $6.32K | – |
| Q2 FY2016 | Jun 30, 2016 | $516.19K | – |
See a number that looks wrong?